Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
MSF treats DR-TB cases
Drug-resistant TB

Access: Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Press Release 21 Mar 2016
 
Drug-resistant TB

New drugs have potential to dramatically improve cure rates for people with severest forms of TB — if access to treatment is improved

Press Release 21 Mar 2016
 
Drug-resistant TB

Report: DR-TB drugs under the microscope, 4th edition

Report 21 Mar 2016
 
Drug-resistant TB

Promising new TB drug priced out of reach for South Africa

Press Release 24 Feb 2016
 
Drug-resistant TB

MSF addresses the growing epidemic of drug-resistant tuberculosis

Patient and Staff Stories 4 Dec 2015
 
Drug-resistant TB

2016: Time for more decentralized DR-TB care in South Africa

Press Release 4 Dec 2015